source
- Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesThe new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a prolific AI biotech inked another deal and Insmed strengthened support for a closely watched…BioPharma Dive · 13d ago↗ source
- Updated: BlossomHill and Latigo join flourishing IPO queue with cancer, pain drugsLast summer, zero biotechs made it onto the public markets as the industry weathered a seven-month dry spell for initial share sales. This time around, it's a summer IPO party as sixEndpoints · 13d ago↗ source
- Compounders maintain a firm grip on the GLP-1 marketDespite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients are still taking cheaper weight-loss alternatives.